Chemsex and LGBTQ+ substance use
The term chemsex refers to the use of specific psychoactive substances , most commonly crystal methamphetamine, GHB/GBL, and mephedrone , in the context of sexual activity, typically between men who have sex with men. It is a pattern of use with specific pharmacological, behavioural, and social characteristics that distinguish it from general recreational drug use, and it is comprehensively underserved by mainstream substance use resources.
This article doesn't assume anything about the reader or their relationship to chemsex. It's an attempt to be genuinely useful , to provide accurate information about what these substances do, what the specific risks are, and what support looks like for people who want it.
What chemsex involves and who is affected
Research from the Kirby Institute and community organisations including ACON consistently finds chemsex concentrated in, but not exclusive to, gay and bisexual men. The practice appears across age ranges and is particularly associated with hook-up apps and urban sexual networks. Australian data suggests a significant minority of gay and bisexual men report chemsex experience, with a smaller proportion reporting regular or recent use.
The drugs specifically associated with chemsex are worth understanding individually:
Crystal methamphetamine produces prolonged arousal, reduced inhibition, reduced need for sleep, and increased sexual desire. It enables extended sexual sessions that would be physiologically impossible without the drug. The specific chemsex appeal is the intensity and duration of the experience , and the toll it takes on the dopamine system and physical functioning is consistent with general methamphetamine use, as described in ice and the early stages, potentially compounded by the physical demands of extended sexual activity.
GHB (gamma-hydroxybutyrate) and GBL (gamma-butyrolactone) are CNS depressants with a disinhibiting effect at low doses and a sedative, sometimes anaesthetic effect at higher doses. GHB has an extremely narrow therapeutic window , the difference between the dose that produces the desired disinhibiting effect and the dose that produces unconsciousness is small. Combined with alcohol, this window narrows further. GHB overdose (sometimes called "G'd out") is a genuine medical emergency involving unconsciousness and aspiration risk, and it is the drug most commonly associated with chemsex-related medical presentations in emergency departments.
Mephedrone (4-MMC) is a synthetic cathinone stimulant with effects broadly similar to MDMA and amphetamines , euphoria, sociability, increased energy. It is less prominent in the Australian market than in the UK, where chemsex research has been most developed, but is present.
The specific risks
The risks associated with chemsex are distinct from general recreational drug use in several ways.
The GHB safety margin is the most acute risk factor. Many chemsex participants use GHB to enhance the experience alongside crystal or mephedrone; the stimulant effects of crystal can mask signs of GHB intoxication, increasing overdose risk. Peer-led harm reduction resources from ACON include guidance on GHB dosing and the importance of never combining with alcohol , the most important single harm reduction message in this context.
Sexual risk behaviour is elevated under chemsex conditions. Research consistently finds increased rates of condomless sex and higher likelihood of multiple partners during chemsex sessions compared to sober sexual activity. This is not a moral observation; it is a risk factor that is relevant to sexual health decisions. Pre-exposure prophylaxis (PrEP) for HIV is widely available in Australia and is a relevant harm reduction tool for sexually active people in networks where HIV transmission is a concern.
Sleep and physical recovery from extended chemsex sessions , which can last days , involves significant physiological debt. Hydration, nutrition, sleep, and the specific recovery from stimulant use all require attention in the days following.
Dependence development in chemsex contexts has specific mechanisms beyond those of general drug use. The pairing of drug use with sexual experience creates powerful conditioning , the neural association between the drug state and sexual arousal can make both sexual activity without drugs feel flat and drug use feel inseparable from sexuality. This conditioning is a recognised feature of chemsex-related dependence and is worth being aware of as a trajectory risk.
Why mainstream substance use resources often miss
The reason chemsex is underserved by general AOD resources is structural. Most substance use support services are oriented toward patterns that don't involve sexual behaviour, toward non-specific populations, and with cultural competence levels around LGBTQ+ experiences that range from adequate to poor. The specific stigma risks around disclosing chemsex behaviour to non-specialist services are real and deter help-seeking.
The more useful resources for people in, or exiting, chemsex patterns are community-based and LGBTQ+-specific:
ACON (NSW) provides chemsex-specific support and harm reduction resources with an understanding of the specific community context.
LGBTIQ+ Health Australia provides national resources and referral pathways.
Ending HIV , the community-facing programme of AFAO , provides harm reduction information with specific sexual health integration.
DirectLine (VIC) and state AOD telephone services can provide referral to services with LGBTQ+ competence.
Self-monitoring in the chemsex context
The structure of chemsex use , typically episodic, associated with specific contexts and cues , makes self-monitoring potentially useful for understanding frequency and trajectory. For people who are concerned about whether their chemsex use is escalating, whether the mood and functioning effects are accumulating, or whether the pattern is narrowing their life in ways they didn't intend, accurate data is the starting point.
An anonymous tool , where there is genuinely no clinical record being created and no identity attached , is particularly important in this context, where the disclosure risks are real and where the privacy concern is legitimate.
ayodee is fully anonymous , no email, no account, no clinical record. Tracks substance use, mood, and wellbeing. ayodee.app.
Want to see your own patterns?
ayodee is a 90-second daily diary for your substance use, mood, and sleep. Anonymous, no email required. Free to start.
Try ayodee free